In cancer cells, NCL becomes aberrantly overexpressed [22,23], translocated to the cell membrane [24,25], and participates in several cancer-driving activities [26,27,28,29,30,31] including biogenesis of oncogenic miRNAs such as miR-21, -103, -221, and -222 [32]. This evidence concerns the gene NUCLEOLIN and cancer.